bafilomycin-a and methylamine

bafilomycin-a has been researched along with methylamine* in 2 studies

Other Studies

2 other study(ies) available for bafilomycin-a and methylamine

ArticleYear
TrkA receptor endolysosomal degradation is both ubiquitin and proteasome dependent.
    Traffic (Copenhagen, Denmark), 2008, Volume: 9, Issue:7

    Gaps in our knowledge exist regarding the degradation of the tropomyosin-regulated kinase A (TrkA) receptor after addition of neurotrophin, nerve growth factor (NGF). TrkA is rapidly and transiently ubiquitinated upon addition of NGF. Here, we demonstrate that the polyubiquitin tag plays a definitive role in receptor sorting. Treatment of PC12 cells with lactacystin prevented NGF-dependent deubiquitination and degradation of TrkA. However, treatment with methylamine, bafilomycin or leupeptin, did not prevent NGF-dependent deubiquitination but blocked the degradation of TrkA. Employing co-immunoprecipitation, biochemical fractionation and confocal microscopy, the kinetics of receptor trafficking post-internalization was observed to occur as a sequel from endosome/multivesicular body, proteasomes, culminating with degradation in the lysosomes. The trafficking of the polyubiquitin-deficient TrkA receptor mutant K485R was impaired and likewise failed to degrade revealing that the receptor escapes degradation. The interaction of TrkA with proteasomes was confirmed by purification and co-immunoprecipitation. We provide evidence that proteasomal deubiquitinating enzymes trim K63-ubiquitin chains from the TrkA receptor prior to its delivery to lysosomes for degradation. Taken together, our results reveal the existence of a novel proteasome-dependent step in receptor degradation.

    Topics: Animals; Endosomes; Humans; Kinetics; Leupeptins; Lysosomes; Macrolides; Methylamines; Mutation; PC12 Cells; Proteasome Endopeptidase Complex; Rats; Receptor, trkA; Subcellular Fractions; Ubiquitin

2008
Evidence for endocytosis-dependent proteolysis in the generation of soluble truncated nerve growth factor receptors by A875 human melanoma cells.
    The Journal of biological chemistry, 1991, Aug-15, Volume: 266, Issue:23

    We have identified nerve growth factor receptor (NGFR) on the cell surface and a truncated nerve growth factor receptor (NGFRt) in the conditioned medium of NGFR-negative cells that have been transfected with either the gene or the cDNA for the full-length receptor. By using cell surface iodination or metabolic labeling of A875 human melanoma cells, coupled with immunoprecipitation, we have determined the half-life of the cell-associated receptor to be approximately 7 h. Concomitant with receptor degradation is the accumulation of NGFRt in the extracellular medium. Approximately one-fifth of the labeled receptor can be recovered as the truncated species. These data support the hypothesis that NGFRt is generated by proteolysis of previously intact receptor. Furthermore, although no specific protease inhibitor assayed could affect this processing, NGFR degradation and truncation were retarded by treatment with: 1) the weak base amines, ammonium chloride or methylamine; 2) the carboxylic ionophore, monensin; or 3) the vacuolar ATPase inhibitor, bafilomycin A1, all agents that dissipate endosomal/lysosomal proton gradients via alternate mechanisms. Incubation of cells at 4 degrees C precluded NGFR degradation and truncation. The presence of ligand did not alter the time course of receptor truncation.

    Topics: Ammonium Chloride; Anti-Bacterial Agents; Blotting, Western; DNA; Electrophoresis, Polyacrylamide Gel; Endocytosis; Endopeptidases; Humans; Hydrolysis; Macrolides; Melanoma; Methylamines; Monensin; Precipitin Tests; Protease Inhibitors; Receptors, Cell Surface; Receptors, Nerve Growth Factor; Transfection; Tumor Cells, Cultured

1991